Jan Harder
- Neurology top 0.5%
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research 11
- Colorectal Cancer Treatments and Studies 3
- Peptidase Inhibition and Analysis 3
- HER2/EGFR in Cancer Research 3
- Epidemiology top 1%
- Neuroendocrine Tumor Research Advances 4
- Hepatology top 5%
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 3
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 8
-
- Gallbladder and Bile Duct Disorders 4
- Co-authors
- Christian ArnoldHans‐Helge MüllerThomas M. GressUlrich‐Frank PapeBehnaz AminossadatiCarmen Schade‐BrittingerAnja RinkePeter Barth
- Cited by
- NeurologyOncologyEpidemiology
- Journals
- British Journal of Cancer (4 papers)Journal of Clinical Oncology (3 papers)World Journal of Gastroenterology (2 papers)
- Partner nations
- GermanyUnited StatesJapan
In The Last Decade
Jan Harder
26 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Neurology 1.3k
- Oncology 2.2k
- Epidemiology 1.8k
- Hepatology 134
- Cancer Research 232
Countries citing papers authored by Jan Harder
This map shows the geographic impact of Jan Harder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Harder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Harder more than expected).
Fields of papers citing papers by Jan Harder
This network shows the impact of papers produced by Jan Harder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Harder. The network helps show where Jan Harder may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jan Harder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 19 | |
| 2 | 2014 | 10 | |
| 3 | 2013 | 0 | |
| 4 | 2013 | 3 | |
| 5 | 2012 | 137 | |
| 6 | 2012 | 71 | |
| 7 | 2012 | 96 | |
| 8 | 2011 | 37 | |
| 9 | 2011 | 57 | |
| 10 | 2010 | 30 | |
| 11 | 2010 | 40 | |
| 12 | Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Groupbreakdown → | 2009 | 1773 |
| 13 | 2009 | 21 | |
| 14 | 2009 | 13 | |
| 15 | 2009 | 75 | |
| 16 | 2009 | 100 | |
| 17 | 2008 | 50 | |
| 18 | 2005 | 0 | |
| 19 | 2004 | 11 | |
| 20 | 2003 | 18 |
About Jan Harder
Jan Harder is a scholar working on Oncology, Software, Cancer Research, Otorhinolaryngology and Surgery, having authored 28 papers that have together received 3.0k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Neuroendocrine Tumor Research Advances (4 papers), Gallbladder and Bile Duct Disorders (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Peptidase Inhibition and Analysis (3 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Neurology (1.3k citations), Oncology (2.2k citations), Epidemiology (1.8k citations), Hepatology (134 citations) and Cancer Research (232 citations). Jan Harder has collaborated with scholars based in Germany, United States and Japan. Frequent co-authors include Christian Arnold, Hans‐Helge Müller, Thomas M. Gress, Ulrich‐Frank Pape, Behnaz Aminossadati, Carmen Schade‐Brittinger, Anja Rinke, Peter Barth, Christina Mayer and Michael Bläker. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, World Journal of Gastroenterology, Clinical Microbiology and Infection and Radiotherapy and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.